West Pharmaceutical Services Net Current Debt 2010-2025 | WST
West Pharmaceutical Services annual/quarterly net current debt history and growth rate from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
- West Pharmaceutical Services net current debt for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- West Pharmaceutical Services net current debt for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
- West Pharmaceutical Services annual net current debt for 2024 was $0B, a 0% decline from 2023.
- West Pharmaceutical Services annual net current debt for 2023 was $0B, a 0% decline from 2022.
- West Pharmaceutical Services annual net current debt for 2022 was $0B, a 0% decline from 2021.
West Pharmaceutical Services Annual Net Current Debt
(Millions of US $) |
| 2024 |
$N/A |
| 2023 |
$N/A |
| 2022 |
$N/A |
| 2021 |
$N/A |
| 2020 |
$N/A |
| 2019 |
$N/A |
| 2018 |
$N/A |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$-1 |
| 2009 |
$-4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$15.565B |
$2.893B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
